Questor : "As ‘variant anxiety’ takes hold, this Covid treatment seems to take them all in its stride We first tipped Synairgen for its antiviral drug last year but got cold feet after the shares doubled. Time to buy again?"
RE: RNS - Director buying more shares29 Apr 2021 09:00
The more the price rises, the more he buys. This is hugely encouraging but also puzzling - he could have exercised options to buy 2.4 million shares at less than 5.5p. I wonder why .....
It is because you bought below mid price. The market does not report the direction of a trade, only time, volume, price and type of trade. LSE guesses anything below or above mid price as a sale or buy.
That would only happen if the the capital raised generates future value at a lower rate per share than existing capital which seems a rather perverse point of view..
The market, like me, clearly thinks this placing is a Good Thing.
Been doing my best t move this today15 Mar 2021 14:13
with buys on three accounts. I also managed to get a spread bet (buy) in in IG first thing and interesting they have now placed this on closing only - suggests they expect volatility?? I think this may the week.
Yes it was an excellent RNS. Trouble is the heid-the-ball Zak Mir followers only feel satisfied when they are ecstatic, anything less than ecstasy is unhappiness and depression (a bit like our North American cousins). As this RNs was only excellent they are now depressed and have to take avoiding action.